An influential Food and Drug Administration committee is set to meet Friday to discuss whether the regulator should approve BioNTech and Pfizer’s COVID-19 booster shot
An influential Food and Drug Administration committee is set to meet Friday to discuss whether the regulator should approve BioNTech and Pfizer’s COVID-19 booster shot